University Medical Center Groningen: clinical-trial pipeline
University Medical Center Groningen is the sponsor of 625 clinical trials in ClinicalTrials.gov and the EU CTIS portal; 150 are not yet finished and 3 were first posted in the last 90 days. Source: Arcadium Data, data as of .
Trials by phase
| Phase | Trials |
|---|---|
| Not applicable | 433 |
| Phase 2 | 60 |
| Phase 4 | 37 |
| Phase 1 | 36 |
| Phase 3 | 24 |
| Phase 1/2 | 23 |
| Phase 2/3 | 7 |
| Early phase 1 | 5 |
Trials by status
| Status | Trials |
|---|---|
| Completed | 308 |
| Unknown | 128 |
| Recruiting | 99 |
| Terminated | 30 |
| Not yet recruiting | 29 |
| Active, not recruiting | 22 |
| Withdrawn or not authorised | 9 |
Condition areas
| Area | Trials |
|---|---|
| Oncology | 207 |
| Cardiovascular | 98 |
| Respiratory | 70 |
| Metabolic and endocrine (diabetes, obesity) | 53 |
| Nephrology and urology | 52 |
| Immunology and rheumatology | 45 |
| Infectious disease and vaccines | 45 |
| Gastroenterology and liver | 39 |
| Neurology | 30 |
| Women's health and obstetrics | 24 |
| Rare and genetic diseases | 23 |
| Psychiatry and mental health | 16 |
Countries
| Country | Trials |
|---|---|
| Netherlands | 565 |
| Germany | 13 |
| Belgium | 11 |
| Spain | 11 |
| Switzerland | 7 |
| Italy | 7 |
| Denmark | 6 |
| United Kingdom | 6 |
| France | 5 |
| United States | 5 |
| Sweden | 4 |
| Austria | 3 |
| Australia | 3 |
| Canada | 3 |
| Portugal | 3 |
Latest changes
| Day | Change | Trial |
|---|---|---|
| 2026-10-08 | New trial posted | Off-line Adaptive Proton Therapy |
| 2026-09-14 | New trial posted | Optimizing Albuminuria Treatment in CKD With Finerenone and Semaglutide |
| 2026-09-03 | New trial posted | Using a Digital Spacer for Inhaler Technique Education in Pediatric Asthma |
Open trials
The 25 most recently changed open trials.
| Registry id | Title | Phase | Status | Countries |
|---|---|---|---|---|
| NCT06304597 | Evaluating PD-1/PD-L1 in Locally Advanced Rectal Cancer by Quantitative Fluorescence Molecular Endoscopy | Phase 1 | Recruiting | Netherlands |
| NCT06616142 | Subtyping Primary Aldosteronism With Para-chloro-2-[18F]Fluoroethyl-etomidate | Phase 1/2 | Recruiting | Netherlands |
| NCT06259422 | Method VALIDation and Evaluation of Non-radioactive Methods to Measure Glomerular Filtration Rate | Not applicable | Recruiting | Netherlands |
| NCT04302454 | Androgen Deprivation Therapy for Oligo-recurrent Prostate Cancer in Addition to radioTherapy | Phase 3 | Active, not recruiting | Netherlands |
| NCT06180733 | Neo-adjuvant Pembrolizumab as an Alternative Treatment for MMRd Uterine Cancer | Phase 2 | Active, not recruiting | Netherlands |
| NCT05929456 | Multispectral Bimodal Fluorescence Guided Surgery of High-grade Glioma With Cetuximab-800CW and 5-ALA (5-amin… | Phase 1 | Recruiting | Netherlands |
| NCT05830396 | GRoningen Early-PD Ambroxol Treatment | Phase 2/3 | Recruiting | Netherlands |
| NCT03938701 | Fluorescence Imaging of IBD and RA Using Adalimumab-800CW | Phase 2 | Recruiting | Netherlands |
| NCT06691464 | FAPI PET/CT to Detect Fibroblast Activity in Non-resolving ARDS | Not applicable | Recruiting | Netherlands |
| NCT05725876 | Quantitative Fluorescence Molecular Imaging of Ustekinumab-800CW to Elucidate the Drug Distribution Throughou… | Phase 1 | Recruiting | Netherlands |
| NCT05641428 | Comparison of Point-of-care Produced CAR T-cell With Commercial CAR T-cells in Patients With R/R LBCL | Phase 2 | Active, not recruiting | Netherlands |
| NCT04593589 | Submandibular Gland Stem Cell Transplantation | Phase 1 | Recruiting | Netherlands |
| NCT05483400 | Open Label Phase 2 Basket Trial With Atezolizumab and Tiragolumab in Solid Tumors | Phase 2 | Active, not recruiting | Netherlands |
| NCT06100081 | Real-time Targeted Fluorescence Endoscopy for Detection of the Primary Cancer Lesion in Patients With a Metas… | Not applicable | Active, not recruiting | Netherlands |
| NCT06782724 | Psilocybin Therapy for Psychological Distress in Palliative Patients | Phase 2 | Not yet recruiting | Czechia, Denmark, Netherlands, Portugal |
| NCT04706715 | LAG3 PET Imaging in Advanced Solid Tumors | Phase 1/2 | Active, not recruiting | Netherlands |
| NCT06534190 | CD8 PET Imaging in Metastatic Solid Tumours | Phase 2 | Recruiting | Spain, United Kingdom, Netherlands |
| NCT06482307 | Molecular Imaging of DNA Damage Response by [18F]-Olaparib PET | Phase 1/2 | Not yet recruiting | Netherlands |
| NCT07196384 | Optical PD-1 and PD-L1 Imaging in Locally Advanced Esophageal Cancer Using Durvalumab-680LT and Nivolumab-800… | Phase 1 | Recruiting | Netherlands |
| NCT06982300 | SSTR2 Imaging With [68Ga]Ga-DOTA-TOC PET/CT in NPC | Phase 1/2 | Recruiting | Netherlands |
| NCT07181135 | FINE-START: Efficacy and Safety of Finerenone in Patients With Chronic Kidney Disease Not Using Renin-angiote… | Phase 3 | Recruiting | Spain |
| NCT07258641 | Fluorescence Imaging of Adalimumab-680LT and Risankizumab-800CW in Inflammatory Bowel Disease | Phase 1/2 | Recruiting | Netherlands |
| NCT06072326 | dApagliflozin SC0062 and Prevention of Renal Injury; a Randomized Evaluation | Phase 2 | Not yet recruiting | Denmark, Finland, Netherlands |
| NCT07527390 | CANagliflozin In DIALysis Patients | Phase 4 | Not yet recruiting | Netherlands |
| NCT07304817 | Comparative Study on the Mode of Action of Vicadrostat and Spironolactone on Protein Profiles and Renal Hemod… | Phase 2 | Recruiting | Netherlands |
All sponsors: clinical-trial pipeline by sponsor.
Track a sponsor's pipeline
The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.
Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.
Cite as: Arcadium Data, "University Medical Center Groningen clinical trials: 150 open, 31 in phase 3", https://arcadiumdata.io/clinical-trials/sponsor/university-medical-center-groningen/, data as of 2026-10-25.